Market Closed -
Other stock markets
|
After market 05:29:57 am | |||
210.73 USD | -8.45% | 211.38 | +0.31% |
06/09 | Equity Markets Slump After Weak Jobs Report | MT |
06/09 | Weak Jobs Report Weighs on Equity Markets | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 24.58B | 31.54B | 53.82B | 81.46B | 96.77B | |||||
Total Revenues | 24.58B | 31.54B | 53.82B | 81.46B | 96.77B | |||||
Cost of Goods Sold, Total | 20.51B | 24.91B | 40.22B | 60.61B | 79.11B | |||||
Gross Profit | 4.07B | 6.63B | 13.61B | 20.85B | 17.66B | |||||
Selling General & Admin Expenses, Total | 2.65B | 3.19B | 4.52B | 3.95B | 4.8B | |||||
R&D Expenses | 1.34B | 1.49B | 2.59B | 3.08B | 3.97B | |||||
Other Operating Expenses | - | - | -27M | 140M | - | |||||
Other Operating Expenses, Total | 3.99B | 4.68B | 7.08B | 7.16B | 8.77B | |||||
Operating Income | 80M | 1.95B | 6.52B | 13.69B | 8.89B | |||||
Interest Expense, Total | -725M | -784M | -358M | -191M | -156M | |||||
Interest And Investment Income | 44M | 30M | 56M | 297M | 1.07B | |||||
Net Interest Expenses | -681M | -754M | -302M | 106M | 910M | |||||
Currency Exchange Gains (Loss) | 48M | -114M | 97M | -89M | 122M | |||||
Other Non Operating Income (Expenses) | 37M | 28M | 25M | 46M | 50M | |||||
EBT, Excl. Unusual Items | -516M | 1.11B | 6.34B | 13.76B | 9.97B | |||||
Restructuring Charges | -87M | - | - | -36M | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Asset Writedown | -15M | - | - | - | - | |||||
In Process R&D Expenses | -47M | - | - | - | - | |||||
Legal Settlements | - | 43M | - | - | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | -665M | 1.15B | 6.34B | 13.72B | 9.97B | |||||
Income Tax Expense | 110M | 292M | 699M | 1.13B | -5B | |||||
Earnings From Continuing Operations | -775M | 862M | 5.64B | 12.59B | 14.97B | |||||
Net Income to Company | -775M | 862M | 5.64B | 12.59B | 14.97B | |||||
Minority Interest | -87M | -141M | -125M | -31M | 23M | |||||
Net Income - (IS) | -862M | 721M | 5.52B | 12.56B | 15B | |||||
Preferred Dividend and Other Adjustments | - | 31M | -5M | -27M | -2M | |||||
Net Income to Common Incl Extra Items | -862M | 690M | 5.52B | 12.58B | 15B | |||||
Net Income to Common Excl. Extra Items | -862M | 690M | 5.52B | 12.58B | 15B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.32 | 0.25 | 1.87 | 4.02 | 4.73 | |||||
Basic EPS - Continuing Operations | -0.32 | 0.25 | 1.87 | 4.02 | 4.73 | |||||
Basic Weighted Average Shares Outstanding | 2.66B | 2.8B | 2.96B | 3.13B | 3.17B | |||||
Net EPS - Diluted | -0.33 | 0.21 | 1.63 | 3.62 | 4.3 | |||||
Diluted EPS - Continuing Operations | -0.33 | 0.21 | 1.63 | 3.62 | 4.3 | |||||
Diluted Weighted Average Shares Outstanding | 2.66B | 3.25B | 3.39B | 3.48B | 3.48B | |||||
Normalized Basic EPS | -0.15 | 0.2 | 1.3 | 2.74 | 1.97 | |||||
Normalized Diluted EPS | -0.15 | 0.17 | 1.13 | 2.46 | 1.8 | |||||
American Depositary Receipts Ratio (ADR) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |||||
Supplemental Items | ||||||||||
EBITDA | 2.17B | 4.27B | 9.43B | 17.44B | 13.56B | |||||
EBITA | 124M | 2B | 6.57B | 13.69B | 8.89B | |||||
EBIT | 80M | 1.95B | 6.52B | 13.69B | 8.89B | |||||
EBITDAR | 2.6B | 4.72B | 10.06B | 18.24B | 14.71B | |||||
Total Revenues (As Reported) | 24.58B | 31.54B | 53.82B | 81.46B | 96.77B | |||||
Effective Tax Rate - (Ratio) | -16.54 | 25.3 | 11.02 | 8.25 | -50.15 | |||||
Current Domestic Taxes | 5M | 4M | 9M | 62M | 105M | |||||
Current Foreign Taxes | 86M | 248M | 839M | 1.27B | 1.24B | |||||
Total Current Taxes | 91M | 252M | 848M | 1.33B | 1.35B | |||||
Deferred Domestic Taxes | -4M | - | - | 27M | -5.9B | |||||
Deferred Foreign Taxes | 23M | 40M | -149M | -223M | -450M | |||||
Total Deferred Taxes | 19M | 40M | -149M | -196M | -6.35B | |||||
Normalized Net Income | -410M | 553M | 3.84B | 8.57B | 6.26B | |||||
Interest Capitalized | 31M | 48M | 53M | - | - | |||||
Interest on Long-Term Debt | 355M | 506M | 159M | 72M | 45M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 27M | - | - | - | - | |||||
Selling and Marketing Expenses | 27M | - | - | - | - | |||||
Research And Development Expense From Footnotes | 1.39B | 1.49B | 2.59B | 3.08B | 3.97B | |||||
Net Rental Expense, Total | 426M | 451M | 627M | 798M | 1.15B | |||||
Imputed Operating Lease Interest Expense | 181M | 215M | 185M | 167M | 188M | |||||
Imputed Operating Lease Depreciation | 245M | 236M | 442M | 631M | 965M | |||||
Stock-Based Comp., COGS (Total) | 128M | 281M | 421M | 594M | 741M | |||||
Stock-Based Comp., R&D Exp. (Total) | 285M | 346M | 448M | 536M | 689M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 482M | 1.11B | 1.25B | 430M | 382M | |||||
Stock-Based Comp., Other (Total) | 3M | - | - | - | - | |||||
Total Stock-Based Compensation | 898M | 1.73B | 2.12B | 1.56B | 1.81B |